Drug utilization review (dur) is defined as an authorized, structured, ongoing review of prescribing, dispensing and use of medication Dur encompasses a drug review against predetermined criteria that results in changes to drug therapy when these criteria are not met. Each state must have a drug utilization review (dur) program to determine which drugs are covered by medicaid and how those drugs are covered In some states, the dur program is managed by a dur board, and in others, it is managed by a p&t committee What is a dur board? A drug utilization review (dur) is a program designed to enhance the safety and effectiveness of prescription drug use
These reviews include studies conducted on drugs prior to their commercial release and public use, as well as ongoing studies after they are prescribed to patients. Drug utilization reviews (dur), also referred to as drug utilization evaluations (due) or medication utilization evaluations (mue), are defined as an authorized, structured, ongoing review of healthcare provider prescribing, pharmacist dispensing, and patient use of medication. A drug utilization review (dur) is a systematic examination of prescription drug use patterns and patient medication histories to ensure the appropriate and safe use of medications. Dur first appeared with the omnibus budget reconciliation act of 1990 (obra ’90) Reduce medicaid fraud and ensure that patients receive appropriate medications. States are required to establish a drug use review board (dur board) that assists the state with dur activities
